A long term study of SPP100 in patients with essential hypertensio
Not Applicable
- Conditions
- Hypertension
- Registration Number
- JPRN-jRCT2080220180
- Lead Sponsor
- ovartis Pharma K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Inclusion Criteria
- Male or female aged 20 to 80 years old
- Diagnosed as essential hypertension
Exclusion Criteria
- Patients with secondary hypertension or suspected of having secondary hypertension.
- Patients suspected of having malignant hypertension
- Patients with any serious diseases or symptoms
Other protocol-defined inclusion/exclusion criteria also apply
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Outcomes: Incidence of adverse events, vital signs, abnormal laboratory changes,etc. Secondary Outcomes: Change from baseline in diastolic blood pressure after 52 weeks; Change from baseline in systolic blood pressure after 52 weeks; Diastolic blood pressure < 90 mmHg or a reduction of > 10 mmHg after 52 weeks
- Secondary Outcome Measures
Name Time Method